Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 110

  • Showing results for richman c. Search instead for Michman C (1 item)

Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis.

Kanate AS, DiGilio A, Ahn KW, Al Malki M, Jacobsen E, Steinberg A, Hamerschlak N, Kharfan-Dabaja M, Salit R, Ball E, Bashir Q, Cashen A, Couriel D, Diez-Martin J, Katsanis E, Linhares Y, Mori S, Nash R, Pawarode A, Perales MA, Phipps CD, Richman C, Savani BN, Shapira MY, Stiff P, Strair R, Fenske TS, Smith SM, Sureda A, Olteanu H, Hamadani M.

Br J Haematol. 2017 Aug 2. doi: 10.1111/bjh.14879. [Epub ahead of print] No abstract available.


Dental Space Deficiency Syndrome: An Anthropological Perspective.

Richman CS.

Compend Contin Educ Dent. 2017 Mar;38(3):180-186.


Implementation of antimicrobial stewardship interventions recommended by national toolkits in primary and secondary healthcare sectors in England: TARGET and Start Smart Then Focus.

Ashiru-Oredope D, Budd EL, Bhattacharya A, Din N, McNulty CA, Micallef C, Ladenheim D, Beech E, Murdan S, Hopkins S; English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR).

J Antimicrob Chemother. 2016 May;71(5):1408-14. doi: 10.1093/jac/dkv492. Epub 2016 Feb 10.


Antimicrobial stewardship: English Surveillance Programme for Antimicrobial Utilization and Resistance (ESPAUR).

Ashiru-Oredope D, Hopkins S; English Surveillance Programme for Antimicrobial Utilization and Resistance Oversight Group.

J Antimicrob Chemother. 2013 Nov;68(11):2421-3. doi: 10.1093/jac/dkt363. Epub 2013 Sep 11.


Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita.

Gadalla SM, Sales-Bonfim C, Carreras J, Alter BP, Antin JH, Ayas M, Bodhi P, Davis J, Davies SM, Deconinck E, Deeg HJ, Duerst RE, Fasth A, Ghavamzadeh A, Giri N, Goldman FD, Kolb EA, Krance R, Kurtzberg J, Leung WH, Srivastava A, Or R, Richman CM, Rosenberg PS, Toledo Codina JS, Shenoy S, SociƩ G, Tolar J, Williams KM, Eapen M, Savage SA.

Biol Blood Marrow Transplant. 2013 Aug;19(8):1238-43. doi: 10.1016/j.bbmt.2013.05.021. Epub 2013 Jun 8.


Comparison of normal tissue pharmacokinetics with 111In/90Y monoclonal antibody m170 for breast and prostate cancer.

Lehmann J, DeNardo GL, Yuan A, Shen S, O'Donnell RT, Richman CM, DeNardo SJ.

Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):1192-8. Epub 2006 Sep 11.


Enhancement of the therapeutic index: from nonmyeloablative and myeloablative toward pretargeted radioimmunotherapy for metastatic prostate cancer.

DeNardo SJ, Richman CM, Albrecht H, Burke PA, Natarajan A, Yuan A, Gregg JP, O'Donnell RT, DeNardo GL.

Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7187s-7194s.


Does paclitaxel (Taxol) given after (111)In-labeled monoclonal antibodies increase tumor-cumulated activity in epithelial cancers?

Miers L, Lamborn K, Yuan A, Richman C, Natarajan A, DeNardo S, DeNardo G.

Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7158s-7163s.


High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human anti-mouse antibody.

Richman CM, Denardo SJ, O'Donnell RT, Yuan A, Shen S, Goldstein DS, Tuscano JM, Wun T, Chew HK, Lara PN, Kukis DL, Natarajan A, Meares CF, Lamborn KR, DeNardo GL.

Clin Cancer Res. 2005 Aug 15;11(16):5920-7.


Inactivation of FGF8 in early mesoderm reveals an essential role in kidney development.

Perantoni AO, Timofeeva O, Naillat F, Richman C, Pajni-Underwood S, Wilson C, Vainio S, Dove LF, Lewandoski M.

Development. 2005 Sep;132(17):3859-71. Epub 2005 Jul 27.


Planning time for peripheral blood stem cell infusion after high-dose targeted radionuclide therapy using dosimetry.

Shen S, DeNardo SJ, Richman CM, Yuan A, Siantar CH, O'Donnell RT, Kroger LA, DeNardo GL.

J Nucl Med. 2005 Jun;46(6):1034-41.


An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California.

Martel CL, Li Y, Beckett L, Chew H, Christensen S, Davies A, Lam KS, Lau DH, Meyers FJ, O'donnell RT, Richman C, Scudder S, Tanaka M, Tuscano J, Welborn J, Wun T, Gandara DR, Lara PN Jr.

Cancer J. 2004 Sep-Oct;10(5):294-300.


Acute myocardial infarction in hemoglobin SC disease.

Wang H, Laslett LJ, Richman CM, Wun T.

Ann Hematol. 2004 Oct;83(10):622-4. Epub 2004 Aug 5.


Blastic mantle cell lymphoma developing concurrently in a patient with chronic myelogenous leukemia and a review of the literature.

Rodler E, Welborn J, Hatcher S, Unger K, Larkin E, Gumerlock PH, Wun T, Richman C.

Am J Hematol. 2004 Apr;75(4):231-8. Review.


Enhanced therapeutic index of radioimmunotherapy (RIT) in prostate cancer patients: comparison of radiation dosimetry for 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-peptide versus 2IT-DOTA monoclonal antibody linkage for RIT.

DeNardo SJ, DeNardo GL, Yuan A, Richman CM, O'Donnell RT, Lara PN, Kukis DL, Natarajan A, Lamborn KR, Jacobs F, Siantar CL.

Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3938S-44S.


Impact of interpatient pharmacokinetic variability on design considerations for therapy with radiolabeled MAbs.

DeNardo G, Yuan A, Goldstein D, Richman C, O'Donnell R, Shen S, Hartmann Siantar C, DeNardo S.

Cancer Biother Radiopharm. 2003 Apr;18(2):231-7.


Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms.

Mohan S, Richman C, Guo R, Amaar Y, Donahue LR, Wergedal J, Baylink DJ.

Endocrinology. 2003 Mar;144(3):929-36.


Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation.

Hutchinson K, Kopko PM, Muto KN, Tuscano J, O'Donnell RT, Holland PV, Richman C, Paglieroni TG, Wun T.

Transfusion. 2002 Dec;42(12):1567-72.


Supplemental Content

Loading ...
Support Center